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Abstract
Berardinelli-Seip congenital generalized lipodystrophy is associated with increased bone
mass suggesting that fat tissue regulates the skeleton. Because there is little mechanistic
information regarding this issue, we generated "fat-free" (FF) mice completely lacking visible
visceral, subcutaneous and brown fat. Due to robust osteoblastic activity, trabecular and
cortical bone volume is markedly enhanced in these animals. FF mice, like Berardinelli-Seip
patients, are diabetic but normalization of glucose tolerance and significant reduction in cir-
culating insulin fails to alter their skeletal phenotype. Importantly, the skeletal phenotype of
FF mice is completely rescued by transplantation of adipocyte precursors or white or brown
fat depots, indicating that adipocyte derived products regulate bone mass. Confirming such
is the case, transplantation of fat derived from adiponectin and leptin double knockout mice,
unlike that obtained from their WT counterparts, fails to normalize FF bone. These observa-
tions suggest a paucity of leptin and adiponectin may contribute to the increased bone mass
of Berardinelli-Seip patients.
Author summary
Berardinelli-Seip congenital generalized lipodystrophy is a human disorder associated
with increased bone mass suggesting that fat, per se, regulates the skeleton. To test this
hypothesis we generated a murine model of congenital generalized lipodystrophy in
which both brown and white adipose tissue are entirely depleted during embryogenesis.
These “fat-free” (FF) exhibit a marked increase in bone mass throughout their body. The
increased bone mass represents stimulation of bone formation and not retarded bone
breakdown. Additionally, the increased bone mass of FF mice markedly increases skeletal
strength and resistance to fracture. Like patients with congenital lipodystrophy, FF mice
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are diabetic but their metabolic state does not contribute to their increased bone mass. To
identify the fat-produced molecules regulating bone mass we transplanted genetically
modified adipose tissue into FF mice which established that absence of the fat-produced
molecules, adiponectin and leptin, significantly enhances bone formation. These observa-
tions suggest that reducing the combined effect of adiponectin and leptin, on bone, will
increase its abundance and fracture resistance.
Introduction
The past decades have witnessed elegant studies of the relationship of energy metabolism and
bone, concluding they are mutually regulatory. By this scenario, selected adipokines influence
skeletal mass by directly and indirectly targeting osteoblasts and osteoclasts [1–4]. These stud-
ies, many of which provide conflicting data, typically involved pharmacologically or genetically
altering adipokine abundance. The realization that different depots of white adipose tissue
(WAT) have distinct physiological effects provided insight into this enigma [5–7]. While sub-
cutaneous fat, residing predominantly in thighs and buttocks, correlates with enhanced bone
mass, increased visceral fat, which characterizes the metabolic syndrome, is associated with
osteoporosis [1–3, 6]. Why this distinction occurs is, however, completely unknown nor is
there mechanistic proof of a cause/effect relationship between fat and abundance of bone.
We reasoned that a mouse mirroring the virtual fat depletion characterizing Berardinelli-
Seip syndrome, with a robust bone phenotype, normalized by adipocyte transplantation,
would be a reasonable venue to establish how "fat talks to bone". This venue would enable
determination of the influence of individual fat depots as well as adipokine-modified adipo-
cytes on the skeleton. Understanding the means by which fat, in its various forms, impacts
bone, may provide a foundation for preventing and treating the skeletal complications of the
metabolic syndrome. To this end, we generated mice completely deficient in WAT as well as
brown adipose tissue (BAT), also postulated to enhance bone mass [8]. While other forms of
murine lipodystrophy, such as the A-ZIP/F1 mouse are associated with some degree of
increased skeletal mass, our fat-free (FF) mice are extremely osteosclerotic due to profound
osteogenesis, despite an abundance of osteoclasts [2]. Consistent with a sympathetic contribu-
tion in both circumstances, reduction of ambient temperature partially reduces the osteo-
sclerosis of fat-depleted mice as well as their WT counterparts. Importantly, transplantation of
WT adipocyte precursors or mature white or brown fat into FF mice completely rescues their
trabecular skeleton. On the other hand, transplantation of adipose tissue derived from leptin
and adiponectin double deficient mice fails to do so. Thus, due at least in part to a paucity of
adipose derived leptin and adiponectin, congenital absence of fat induces severe osteosclerosis
by stimulating bone formation. These observations provide insight into the mechanisms of
enhanced skeletal mass in human congenital generalized lipodystrophy (CGL) and suggest
that reducing the combined effect of adiponectin and leptin, on bone, will increase its
abundance.
Results
Generation of FF mice
As described [9] generation of FF mice involved crossing those bearing a diphtheria toxin
(DTA) transgene downstream of a floxed stop codon (DT-STOPfl/fl) to mice expressing adipo-
nectin Cre (+/-). Cre- littermates serve as control. In keeping with the unique expression of
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adiponectin Cre in adipocytes and their precursors all Cre+ products of the mating contain no
discernable WAT confirmed by virtually undetectable circulating adiponectin or leptin as well
as visfatin and, resistin [10] (Fig 1). BAT is also absent and as a result, FF mice are cold intoler-
ant as they require housing at 30˚C to survive prior to weaning. Unexpectedly, the abundance
of marrow adipocytes is unaltered in FF mice. Body weight of FF mice progressively dimin-
ishes with age, relative to WT, but the difference does not reach statistical significance until 20
weeks. There is no alteration of growth as evidenced by femoral length and FF mice have sub-
stantial splenomegaly (S1 Fig).
Congenital absence of fat promotes osteosclerosis
X-rays reveal the radiodensity of the FF skeleton is markedly increased (Fig 2A). This increase
in trabecular bone mass is evident as early as 3 weeks post-partum. It maximizes at 2 months
of age when BV/TV of FF mice is markedly greater than their WT littermates (Fig 2B and 2C,
Fig 1. FF mice have undetectable serum adipokines. Serum adipokines of control and FF mice. Data are presented as mean ± SD. ��� p<0.001 as determined by
unpaired t test.
https://doi.org/10.1371/journal.pgen.1008244.g001
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Fig 2. Congenital absence of fat promotes osteosclerosis. A) Radiographs of femurs of 3 month old control and FF mice. B) Age-dependent μCT images of
femurs of FF and control littermates. C) Quantitative μCT analysis of B. D) Histomorphometric analysis of trabecular bone volume of 3 month old FF and control
tibia. E) μCT images of vertebrae (L3-5) of 3 months old control and FF littermates. F) Quantitative μCT analysis of trabecular bone volume and bone mineral
density of E. Data are presented as mean ± SD. �p<0.05; ��p<0.01; ��� p<0.001 as determined by unpaired t test (D, F) and 2 way ANOVA with Holm-Sidak’s post
hoc analysis for multiple comparisons test (C).
https://doi.org/10.1371/journal.pgen.1008244.g002
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S2A Fig). The increase in FF trabecular bone mass is also evident histomorphometrically (Fig
2D). The osteosclerotic phenotype of fat-depleted mice is present in long bones and vertebrae
(Fig 2E and 2F, S2B Fig).
Femoral cortical thickness of FF mice does not increase above control until 8 weeks and in
fact, total area is reduced until that age (S3 Fig). The enhanced bone area and bone area/total
area in 8 week old mice indicates that their decreased medullary area represents augmented
cortical thickness due to accelerated endosteal MAR.
Congenital absence of fat increases bone formation
Augmented bone mass may represent enhanced osteogenesis and/or decreased resorption.
Increased circulating osteocalcin as well as collagen1 α1, osteocalcin and osteopontin mRNAs,
in bone, suggests stimulated osteoblast activity contributes to the osteosclerotic phenotype of
FF mice (Fig 3A and 3B). To confirm such is the case, we administered time-spaced courses of
calcein. Histomorphometric analysis reveals marked acceleration of trabecular bone formation
in FF mice manifest by activity of individual osteoblasts (MAR) as well when expressed in the
context of trabecular surface (BFR/BS) and total bone formation rate (BFR) (Fig 3C and 3D).
In keeping with increased cortical thickness, osteoblasts lining the cortical endosteal surface of
FF mice assume the columnar appearance of those actively synthesizing bone (Fig 3E). Sup-
porting this conclusion, endocortical MAR is enhanced (Fig 3F) resulting in decreased
Fig 3. Congenital absence of fat promotes bone formation. A) Serum osteocalcin of FF and control mice. B) qPCR analysis of osteoblast differentiation markers
present in RNA extracted from femurs of 6-week old FF and control mice. C) Fluorescence microscopic images of distal femur of control and FF mice administered
time-spaced calcein. Scale bar: 400 μm. D) Histomorphometric analysis of total bone formation rate (BFR), bone formation rate per mm trabecular surface (BFR/BS)
and mineral apposition rate (MAR) of trabecular bone. E) TRAP stained (red reaction product) control and FF femur. FF endocortical surface is lined by columnar
osteoblasts (arrows) characteristic of robust bone formation. Scale bar: 800 μm. F) Histomorphometric analysis of endocortical MAR. G) Histomorphometric analysis
of periosteal MAR. Data are presented as mean ± SD. �p<0.05; ��p<0.01; ���p<0.001 as determined by unpaired t test.
https://doi.org/10.1371/journal.pgen.1008244.g003
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medullary area (S3B Fig). Unlike endocortical, periosteal MAR is not significantly altered in
FF mice (Fig 3G).
We next determined the quantity and percentage of marrow cells expressing leptin receptor
(LepR) which are reported to provide a majority of osteoblast and adipocyte progenitors [11].
Predictably, in face of markedly decreased abundance of marrow, due to its replacement by
bone, the number of LepR+ cells is substantially less in FF than WT mice (S4A Fig). On the
other hand, the percentage of marrow cells expressing LepR is also markedly reduced in FF
mice indicating selective diminution (S4B Fig). Unexpectedly, in face of total ablation of
peripheral adipose tissue, the abundance of marrow adipocytes is unaltered in FF mice (S4C
Fig). These observations posit that while adiponectin Cre/DT fails to target mature marrow
adipocytes in FF mice, it diminishes LepR+ precursors. Preservation of marrow adipocytes
and the abundance of bone forming osteoblasts, suggest that progenitors other than those
expressing LepR are functional in FF mice. This conclusion is consistent with the observation
that LepR+ MSCs serve as adipocyte and osteoblast precursors only in adult mice. Alterna-
tively, recent single cell RNA-seq based evidence establishes LepR+ cells are heterogeneous
with specific subsets representing osteogenic and adipogenic precursors [12]. Thus it is possi-
ble that germ-line fat ablation selectively depletes osteogenic LepR+ subpopulations while
maintaining those which are adipogenic.
Congenital absence of fat increases osteoclast number but not function
Bone remodeling is an ever-occurring event characterized by a tethering of osteoblast and osteo-
clast number. Thus, in keeping with the increase in bone formation in FF mice, circulating TRAP
5b, a classical marker of osteoclast abundance, is significantly higher than that of WT counterparts
(Fig 4A). The increased number of osteoclasts is confirmed by histomorphometry (Fig 4B). Osteo-
clast specific mRNAs are also enhanced in FF bone (Fig 4C). Many FF osteoclasts fail, however, to
attach to bone and have an irregular appearance suggesting cytoskeletal and resorptive dysfunc-
tion [13] (Fig 4D). While circulating CTx of WT and FF mice are equivalent (approximately 15
ng/ml each), serum CTx, normalized to the osteoclast abundance marker, TRAP5b, is reduced
confirming the resorptive activity per individual cell is decreased (Fig 4E). Thus, osteoclastic bone
resorption does not contribute to the skeletal phenotype of fat-depleted mice.
Congenital absence of fat enhances bone strength
Increased bone mass normally amplifies the mechanical properties at the whole-bone (struc-
tural) level [14]. As such, three-point bending tests indicate that femora of 12week old FF mice
are significantly stiffer (Fig 5A) with enhanced ultimate force (Fig 5B), the latter indicating
superior whole-bone strength. These differences are consistent with increased bone area (Fig
5C) and cortical thickness (S3B Fig) although total area (S3B Fig) and moment of inertia
(pMOI; Fig 5D) are not different. The morphological properties of FF femora reflect increased
bone mass and are consistent with the enhanced endocortical but not periosteal bone forma-
tion noted above (Fig 3F and 3G). Bending tests also reveal FF femora have lower post-yield
displacement (Fig 5E) and work-to-fracture (Fig 5F), indicating a more brittle phenotype.
Thus, FF femora are stiffer and stronger at the whole-bone level, consistent with greater bone
mass. On the other hand, FF bones have reduced post-yield displacement leading to reduced
work-to-fracture and in keeping with more brittle material properties.
Bone mass of FF and WT mice is thermogenically regulated
While our data confirm that fat depletion induces profound osteogenesis, we have not estab-
lished whether the FF environment directly and/or indirectly stimulates osteoblasts. This is
Lipodystrophy induces osteosclerosis
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particularly relevant as regards the sympathetic nervous system (SNS) as its activation may
dampen osteogenesis via β-adrenergic receptors [15]. Because heat regulates skeletal mass,
most likely via SNS activity, we asked if the osteosclerosis of FF mice is impacted by the tem-
perature to which they are exposed. Thus, at weaning, FF and control littermates were main-
tained as usual, at 30˚ or at room temperature (23˚) for 3 months. Consistent with sympathetic
regulation, bone mass of FF mice, maintained at 23˚C, is diminished relative to those kept at
30˚C (Fig 6A). On the other hand, comparable ambient temperature regulation of bone mass
also occurs in control mice. Given these similar environmental effects in both genotypes it is
unlikely that differences in sympathetic tone account for the profound osteosclerosis of FF
mice.
Osteosclerosis of congenital generalized lipodystrophy is not caused by the
metabolic syndrome
Type 2 diabetes-associated humoral factors, such as insulin, have skeletal effects. In keeping
with their lipodystrophic state, FF mice are insulin resistant as documented by abnormal insu-
lin and glucose tolerance tests (Fig 6B–6D) and severe hepatic steatosis (see below) [9]. To
Fig 4. Congenital absence of fat increases osteoclast number but not function. A) Serum TRAP5b of FF and control mice. B) Histomorphometric analysis of
osteoclast number/mm bone surface. C) qPCR analysis of osteoclast differentiation markers present in RNA extracted from femurs of 6-week old FF and control mice.
D) TRAP stained FF and control bones. Scale Bar: 100 μm. E) Ratio of serum CTx to TRAP5b of FF and control mice. Data are presented as mean ± SD. �p<0.05;
��p<0.01; ���p<0.001 as determined by unpaired t test.
https://doi.org/10.1371/journal.pgen.1008244.g004
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determine if metabolic abnormalities likely contribute to their osteosclerotic phenotype, we
fed metformin, standard therapy for lipodystrophy-associated diabetes, to 3 week old FF mice,
maintained at 30˚C [16]. The animals were sacrificed after 3 months. While the drug normal-
izes glucose tolerance and significantly reduces circulating insulin it has no effect on bone
mass of FF mice (Fig 6B, 6E and 6F; S5 Fig). Interestingly, unlike ovariectomized rats housed
at room temperature, whose skeletal mass increases in response to metformin, that of Cre- lit-
termates of FF mice is unaffected [17]. Thus, the osteosclerosis of FF mice likely does not
meaningfully reflect their metabolic dysfunction.
Transplanted WT adipose tissue normalizes the congenital generalized
lipodystrophic skeleton
We hypothesized that the skeletal effects of various fat depots and genetically modified adipo-
cytes may be clarified by their transplantation into mice with CGL. To this end we subcutane-
ously transplanted 3x106 mouse embryonic fibroblasts (MEFs) which differentiate into WAT,
into 2 month old FF mice (Fig 7A and 7B) [18]. Within 4 months, transplantation of these adi-
pocyte progenitors eliminates hepatic steatosis (Fig 7C) and completely reverses the trabecular
osteosclerotic phenotype of the mutant mice (Fig 7D–7F; S6 Fig). To determine if the same
occurs in the context of mature fat depots, we transplanted gonadal (visceral) or subcutaneous
WAT or brown adipose tissue (BAT) into FF mice. Consistent with equivalent serum levels
of adiponectin and leptin (S7A Fig), in each circumstance, trabecular bone mass, completely
normalizes (Fig 7G and 7H, S7B and S7C Fig). Likely reflecting relative slow rate of bone
Fig 5. Congenital absence of fat enhances bone strength. Bending tests analysis of FF and control femoral (A) stiffness and (B) ultimate force (a measure of whole-
bone strength). (C) μCT analysis of diaphyseal bone area. (D) Polar moment of inertia. (E) Post-yield displacement. (F) Work to fracture. Data are presented as
mean ± SD. �p<0.05; ��p<0.01 as determined by unpaired t test.
https://doi.org/10.1371/journal.pgen.1008244.g005
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Fig 6. Osteosclerosis of FF mice is not caused by the metabolic syndrome. A) Femoral trabecular bone volume of control and FF
mice maintained for 3 months at 23 C (RT) or 30 C. B) Serum insulin of FF mice with or without metformin treatment. Control mice
Lipodystrophy induces osteosclerosis
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remodeling, cortical thickness is unaffected after 4 months (S7D Fig). The rescue capacity of
BAT likely does not reflect its effect on energy expenditure as mice with UCP1-Cre mediated
BAT deletion exhibit no skeletal phenotype (S8 Fig). Thus, WT adipose tissue, regardless of
origin, normalizes the FF skeleton suggesting mediation by commonly produced factors
which, in the case of BAT, may reflect its “whitening” due to initial exposure to excess circulat-
ing lipids attending lipodystrophy [19] or transplanted BAT loss of sympathetic innervation.
Absence of leptin and adiponectin moderates FF osteosclerosis
Prior, albeit controversial, evidence indicates leptin and/or adiponectin exert skeletal effects
[1, 2, 4]. Additionally, both adipokines are expressed by visceral, subcutaneous and brown adi-
pocytes [20]. We therefore transplanted WT, leptin-/- (ob/ob), adiponectin-/- or double-defi-
cient (DKO) WAT into FF mice. Three months later, the abundance of transplant-derived
mutant fat was at least as great as WT (Fig 8A and 8B). Interestingly, in face of the capacity of
transplanted WT WAT to completely normalize the FF skeleton, circulating leptin and partic-
ularly adiponectin, are substantially less in recipient mice than their naïve WT counterparts
(Fig 8C). As expected, plasma of leptin-/- and adiponectin-/- grafted FF mice is completely
devoid of their respective adipokine. While adiponectin-deficient grafts yield circulating leptin
mirroring that of WT fat recipients, adiponectin is minimal in FF mice receiving leptin-/- fat.
As leptin-/- fat is derived from obese ob/ob mice, the paucity of adiponectin is in keeping with
the inverse relationship of the cytokine’s expression and fat mass. μCT analysis established that
absence of both leptin and adiponectin markedly reduces the capacity of WAT to normalize
FF osteosclerosis (Fig 8D; S9A Fig). While a similar trend occurs in fat lacking either one of
the cytokines, the distinction with WT fat transplantation is not significant. On the other
hand, osteoclast number normalizes in FF mice regardless of adipokine expression (S9B Fig).
Circulating TNFα is slightly but significantly increased in FF mice and normalized by fat trans-
plantation (S9C Fig). Thus, absence of leptin and adiponectin, particularly when combined,
contributes to the osteosclerotic phenotype of congenital generalized lipodystrophy.
Discussion
Among the most controversial issues relating to the metabolic syndrome is the effect of obesity
on bone, resolution of which will require an understanding of whether adipose tissue, per se,
regulates skeletal biology and if so, what are the mechanisms? CGL is a rare disorder but
potentially provides insights into the relationship of fat and the skeleton. For example, Berardi-
nelli-Seip children grow rapidly and have advanced bone age. While not universal, bone mass
of many CGL patients is substantially increased, a phenomenon which appears dictated by the
specific causative mutation [21, 22].
We reasoned that generation of a completely fat-deficient mouse would permit use of adi-
pose tissue transplantation to assess the effect of fat on the skeleton and most importantly,
identify fat-residing bone-regulating molecules. To this end, we genetically targeted DTA to
fat using adiponectin (Adipoq) Cre [7, 10]. All Cre+ mice are devoid of visible WAT and BAT.
While other lipodystrophic mice, such as A-ZIP/F1, are osteosclerotic, we utilized FF mice
because of their unique lack of any detectable peripheral fat depots [23]. Furthermore, for
serve as normal control. C) Glucose tolerance test of 2 month old FF and control littermates. D) Insulin tolerance test of 2 month old
FF and control littermates. E) Glucose tolerance test of FF and control mice after 3 months treatment with or without metformin. F)
μCT quantitative analysis of distal femurs of FF and control mice following 3 months with or without metformin. Data are presented
as mean ± SD. �p<0.05; ��p<0.01; ���p<0.001; NS: no significance as determined by 1 way ANOVA (B) and 2 way ANOVA with
Holm-Sidak’s post hoc analysis for multiple comparisons test (A,C,D,E,F).
https://doi.org/10.1371/journal.pgen.1008244.g006
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Fig 7. Transplanted WT adipose tissue normalizes FF skeleton. A) Left: Fat mass (arrow) in FF mouse 4 months after subcutaneous MEF transplantation.
Right: WT MEF transplantation normalizes liver size of FF liver (star). B) Histological image of Fat mass in FF mouse 4 months after subcutaneous MEF
Lipodystrophy induces osteosclerosis
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reasons unknown, marrow adipocyte abundance is unaltered in FF mice establishing that their
osteosclerosis is mediated by peripheral adipose tissue, a conclusion confirmed by the com-
plete rescue of their skeletal phenotype by gonadal, subcutaneous or brown adipose tissue. On
the other hand, while FF mice mimic the phenotype of Berardinelli-Seip lipodystrophy, the
pathogenesis of each differ as the human disorder is genetically based and that of the FF
mouse represents adipocyte ablation [24].
Increased bone mass reflects enhanced osteoblast and/or retarded osteoclast function, an
issue unresolved in lipodystrophic mouse models or patients. Bone formation is extremely
robust in FF mice, a reflection of abundant osteoblasts and hyperactivity of the individual cell.
This observation, taken with increased circulating osteocalcin, substantiates FF osteosclerosis
is a manifestation of heightened osteogenesis.
Osteoclasts are abundant in FF mice. While circulating TNFα, a potent osteoclastogenic
cytokine, is also significantly enhanced and normalized by transplanted fat, abundance of the
cytokine, even in the naïve mutant mouse, is relatively low calling to question whether it con-
tributes to increased osteoclast number [25]. While unproven, a more likely scenario holds
that the abundant osteoblasts produce osteoclastogenic cytokines such as RANK ligand. Alter-
natively, the morphological features of cytoskeletal disorganization and diminished mobiliza-
tion of CTx normalized to circulating TRAP5b, a marker of osteoclast number, indicate
resorptive function of individual osteoclasts is compromised. Thus, net resorptive activity
likely does not contribute to the FF bone phenotype. On the other hand, poorly resorbing oste-
oclasts may enhance skeletal mass by stimulating bone formation [26–28]. This event likely
reflects the fact that osteoclasts promote osteogenesis not only by mobilizing matrix-residing
osteoblast-activating growth factors, but also by secreting osteoblast-recruiting proteins inde-
pendent of their resorptive activity. Thus, while the rate of bone formation of osteopetrotic
mice, which lack osteoclasts, is suppressed, it is enhanced in those rich in dysfunctional poly-
karyons [28]. The same holds regarding therapy for pathological bone loss. Anti-resorptive
drugs such as bisphosphonates which kill osteoclasts also suppress osteogenesis, whereas oda-
nacatib, which impairs function of osteoclasts but does not diminish their abundance, substan-
tially spares bone formation [29].
Among the most important contributions to understanding osteoblast biology is the discov-
ery that their activity is sympathetically regulated and adipokines, at least in part, exert their
skeletal effect by this mechanism [1, 15]. There is also evidence that maintaining mice at 23˚C
reduces their trabecular bone mass relative to those housed at 30˚C [30]. Given that reduced
ambient temperature activates the SNS, a reasonable hypothesis holds that FF mice, kept at
room temperature, will have less bone than those maintained at thermoneutrality and we find
such to be the case. On the other hand, the same occurs in WT mice indicating that while FF
osteosclerosis may be SNS regulated, it likely occurs as a physiological event and not reflective
of fat depletion.
As expected, given their lipodystrophic phenotype, FF mice are insulin resistant and steato-
tic. We propose these metabolic features add significance to the FF model as they replicate the
complications of human CGL. Regarding a possible influence of the FF metabolic state on
transplantation; Scale bar: 1mm. C) Histological images of FF liver showing severe steatosis (left Panel) in sham operated mice and its elimination by MEF
transplantation (right Panel). Scale bar: 400μm. D) μCT images and E) quantitative analysis trabecular volume and bone mineral density of distal femurs of FF
mice 4 months after sham operation or MEF transplantation. F) Histomorphometric analysis of tibial trabecular bone volume and osteoclast number in WT
controls and FF mice 4 months after sham operation or MEF transplantation. G) Radiographs of femurs of FF mice 3 months after sham operation or
transplantation of various fat depots. H) μCT analysis of trabecular bone volume and bone mineral density of distal femurs of FF mice 3 months after sham
operation or transplantation of various fat depots. Data are presented as mean ± SD. �p<0.05; ��p<0.01; ��� p<0.001 as determined by ANOVA with Holm-
Sidak’s post hoc analysis for multiple comparisons test.
https://doi.org/10.1371/journal.pgen.1008244.g007
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enhancing bone mass, evidence indicates the opposite. Specifically, fatty liver disease does not
increase bone mass and in fact, promotes osteoporosis [31]. Moreover the bone mass of high
fat-fed, insulin-resistant C57/BL6 mice is also decreased due to arrested bone formation [32].
Given its osteosclerotic properties and our observation that pharmacological modification of
their diabetic state does not affect bone mass, it is unlikely that the metabolic syndrome of FF
mice contributes substantially to their osteosclerosis and in fact may exert a negative influence
superseded by robust osteogenesis.
The augmented bone mass in FF mice is contrary to the normal positive association
between body size and bone mass. We recently showed in a large cohort of Large-by-Small
advanced intercross (LG,SM AI) mice, which are WT but have a broad range of body mass
due to genetic variation [33], that femur size and strength correlate positively with body and
fat mass as well as serum leptin [34]. Thus, the osteosclerosis of FF mice is clearly counter to
the normal physiology that links body size to bone mass. Nonetheless, biomechanical testing
reveals that femora of FF mice are mechanically robust, with elevated stiffness and failure load
in proportion to their increased mass. Thus, the excess bone in FF mice is mechanically com-
petent. The only indication of possibly compromised bone properties in FF mice is decreased
post-yield displacement and work-to-fracture, which reflects relatively brittle behavior of
unclear origin.
We initiated this exercise to address two controversial issues relating to fat-mediated modu-
lation of the skeleton. Both involved rescue of the CGL phenotype by fat transplantation which
we first did using MEFs differentiating into adipocytes. Determining the capacity of subcuta-
neous and visceral WAT to alter FF osteosclerosis involved transplantation of WT individual
depots into the affected mice. The fact that each depot completely normalizes FF bone suggests
absence of a commonly-produced molecule(s) dampens bone formation. Moreover, reduction
of bone mass by transplanted BAT challenges the commonly held position that these energy
consuming adipocytes positively affect the skeleton [35]. The failure of UCP1 deletion, in adi-
pose tissue, to impact bone mass, indicates that cure of FF osteosclerosis by BAT does not
involve uncoupled energy expenditure.
A number of adipokines are proposed to impact the skeleton, most prominently, leptin and
adiponectin which are virtually absent in CGL patients [36]. Despite great interest in these pro-
teins, their skeletal properties are controversial. There is evidence that leptin diminishes bone
mass by sympathetic activation via hypothalamic targeting [1, 15]. Other studies, however pro-
pose a direct effect on osteoblasts. In keeping with our observation that LepR+ marrow cells
are diminished in FF mice, deletion of these cells promotes osteogenesis [37]. Alternatively,
some argue that the cytokine actually increases bone mass [38–40]. The skeletal properties of
adiponectin are equally complex with a majority of in vivo reports indicting osteoblast sup-
pression while in vitro studies propose osteoblast stimulation [41]. Like leptin, both central
and direct targeting of osteoblasts, by adiponectin, are postulated [4].
Transplanted WT fat completely normalizes FF bone in face of a paucity of circulating lep-
tin and adiponectin relative to naïve WT mice. Thus, minimal expression of these adipokines
may be sufficient to mediate the inhibitory effects of fat on osteogenesis and their absence
likely contributes to lipodystrophy-associated osteosclerosis although lack of other adipocyte
expressed factors, such as PPARU, may participate [2, 42, 43]. While surprising, this
Fig 8. Absence of leptin and adiponectin moderates FF osteosclerosis. A) Transplanted fat depots 3 months after surgery. B) Fat depot weight 3 months after
transplantation. C) Serum leptin and adiponectin of FF mice 3 months after fat depot transplantation. WT and non-transplanted FF mice serve as control. D) μCT
analysis of trabecular bone volume and bone mineral density of distal femurs of FF mice 3 months after sham operation or transplantation of fat derived from WT
or adipokine-deficient mice. Data are presented as mean ± SD. ��p<0.01; ��� p<0.001 as determined by ANOVA with Holm-Sidak’s post hoc analysis for multiple
comparisons test. D) comparison with FF Sham except where detailed.
https://doi.org/10.1371/journal.pgen.1008244.g008
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observation is in keeping with the capacity of small amounts of leptin to reverse the metabolic
complications of lipodystrophy and the substantially greater bone mass in FF relative to other
lipodystrophic mice with some residual fat [2]. On the other hand, individual deletion of either
cytokine is not as effective as absence of both in maintaining the enhanced bone mass of FF
mice. Whether this distinction reflects minimal expression of the other adipokine remains to
be determined.
Materials and methods
Ethics statement
Animal work was performed according to the policies of Animal Studies Committee (ASC) at
Washington University School of Medicine in St. Louis. Mice were analyzed under approved
protocols and were provided appropriate care while undergoing research which complies with
the standards in the Guide for the Use and Care of Laboratory Animals and the Animal Wel-
fare Act.
Mice
Fat Free (FF) mice were generated by mating homozygous Lox-stop-Lox-ROSA-DTA mice to
those expressing adiponectin-Cre. BAT-deficient mice were generated by mating homozygous
Lox-stop-Lox-ROSA-DTA mice to those expressing UCP1-Cre. Although no gender differences
exist in phenotype, male mice were exclusively used. Adiponectin-/-, leptin -/- mice were pur-
chased from Jackson laboratory. Adiponectin/Leptin double knock-out (DKO) mice were cre-
ated by mating Adiponectin-/- and Leptin +/- animals.
Metformin was purchased from MP Biomedicals (Santa Ana, California) and dissolved in
mouse drinking water (2 g/L) for an equivalent dose of 300 mg/kg per day, based on estimates
that mice drink 1.5 mL/10 g body weight per day [44]. Fresh drinking water with Metformin
was changed daily for 3 months.
Serum ELISA assay
Blood was collected retro-orbitally under anesthesia immediately prior to sacrifice. Serum was
obtained using serum separator tubes with lithium heparin (Becton Dickinson) and kept at
-80C. ELISA kits were purchased from: Mouse adiponectin, leptin, adipsin, resistin and TNFα
ELISA kits from R&D; Mouse Viafatin and Insulin ELISA kit from Ray biotech (Norcross,
GA); Serum CTx-1 and TRAP5b kits from Nordic Bioscience; osteocalcin ELISA kit from Bio-
medical Technologies Inc.
RNA extraction and quantitative qPCR
Total RNA from fresh bone was extracted using Trizol following RNA purification with
RNeasy RNA purification kit and RNase free DNase digestion (Qiagen). Complementary
DNA (cDNA) was synthesized from 1 μg of total RNA using the iScript cDNA synthesis kit
(Bio-Rad). Quantitative qPCR was performed using the PowerUp SYBR Green Master Mix kit
(Applied Biosystems) according to the kit instruction and gene specific primers. All genes
amplicon length is less than 150 nucleotides. PCR reactions for each sample were performed
with 7500 fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using the
comparative threshold cycle (Ct) method for relative quantification. The glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) gene was used as an endogenous control. The
sequences of primers are: Itgb3: forward: TTCGACTACGGCCAGATGATT, reverse: GGA
GAAAGACAGGTCCATCAAGT; Ctsk: forward: AGGCAGCTAAATGCAGAGGGTACA,
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reverse: AGCTTGCATCGATGGACACAGAGA; Trap: forward: CAGCTCCCTAGAAGATG
GATTCAT, reverse: GTCAGGAGTGGGAGCCATATG; Dcstamp: forward: ACTAGAGGA
GAAGTCCTGGGAGTC, reverse: CACCCACATGTAGAGATAGGTCAG; Nfatc1: forward:
CCCGTCACATTCTGGTCCAT, reverse: CAAGTAACCGTGTAGCTGCACAA; Atp6v0d2:
forward: CAGAGCTGTACTTCAATGTGGAC; reverse: AGGTCTCACACTGCACTAGGT;
Bglap: forward: CTGACCTCACAGATGCCAAG, reverse: GTAGCGCCGGAGTCTGTTC;
Opn: forward: GATTTGCTTTTGCCTGTTTGG, reverse: TCAGCTGCCAGAATCAGTCA
CT; Col1a1: forward: GAGCGGAGAGTACTGGATCG, reverse: GTTAGGGCTGATGTAC
CAGT; Gapdh: forward: AGGTCGGTGTGAACGGATTTG, reverse: TGTAGACCATGT
AGTTGAGGTCA.
Flow cytometry
Bone marrow was isolated from the femur using the spin-flushing method, as previously
described (Rohatgi et al., Blood Advances, 2018). Bone marrow cells from one femur/mouse
were washed once in 200 μL PBS and then pelleted via centrifugation at 500 x g for 5 min at
4˚C. Cells were resuspended in 50 μL of dead cell exclusion dye (ZombieUV, 1:600 in PBS,
BioLegend) and incubated on ice for 10 min covered in foil. The ZombieUV stain was
quenched with 200 μL FACS Buffer (PBS containing 2.5% heat-inactivated FBS and 2.5 mM
EDTA), and cells were collected via centrifugation, as above. Cells were resuspended in 50 μL
FcBlock (10 μg/mL of rat anti-mouse CD16/32 antibody, clone 2.4G2, BD Biosciences) and
incubated on ice for 10 min covered in foil. An equal volume (50 μL) of 2X concentrate of pri-
mary antibody cocktail was added for a final staining volume of 100 μL. The primary antibody
cocktail contained rat anti-mouse CD45-BUV395 (BD Horizon, clone 30-F11, final dilution
factor 1:200), rat anti-mouse TER-119-APC (BioLegend, clone TER-119, 1:200), rat anti-
mouse CD41-BV421 (BioLegend, clone MWReg30, 1:300), rat anti-mouse/human CD11b
(BioLegend, clone M1/70, 1:400), and rat-anti mouse Leptin receptor (LepR)-biotin (R&D Sys-
tems, polyclonal, 1:50) in Brilliant Stain Buffer (BD Biosciences) containing 10 μg/mL FcBlock.
Cells were stained for 30 min on ice and then washed 3 times in 200 μL FACS Buffer. The cells
were resuspended in 100 μL of streptavidin-PE/Cy7 (BioLegend) and incubated on ice for 20
min before being washed 3 times in 200 μL FACS Buffer. Cells were resuspended in 200 μL
FACS Buffer, and CountBright Absolute Counting Beads (Molecular Probes, 25 μL) were
added to quantify total cell numbers using lot-specific bead concentration of 51,000 beads per
50 μL (Lot number 2014181). Flow cytometry data were analyzed with FlowJo version 10 (Bec-
ton, Dickinson & Company). LepR+ stromal cells were defined as singlet, live, CD45–, TER-
119–, CD41–, CD11b–, LepR+ cells.
GTT and ITT
Glucose tolerance tests (GTT) were performed on 2 month old male mice in clean cages sub-
jected to starvation with free access to water for 6 hours. Mice were weighed and a small
amount of blood was obtained from tail vein for baseline (time 0) glucose measurement. Mice
were then injected intraperitoneally with 50% sterile dextrose (1 mg/g body weight). Tail
blood glucose was determined at 15, 30, 60, 90 and 120 min after challenge using a Bayer Con-
tour glucometer. For insulin tolerance test (ITT), 2 month old male mice were placed in clean
cages without food and free access to water. Following a 6 hr fast, the mice were weighed and
baseline glucose reading was taken using Bayer Contour glucometer. Mice were injected intra-
peritoneally with human insulin (Humulin, Eli-Lilly) at a dose of 0.7U/Kg body weight and
blood glucose measured at 15, 30, 45, 60, 90, 120 min after insulin injection.
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Histology and histomorphometry
Femur and Tibia were fixed in 10% neutral buffered formalin, followed by decalcification in
14% EDTA for 10 days, paraffin embedding, and TRAP staining. Static and dynamic histo-
morphometric parameters were measured using BioQuant OsteoII (BioQuant Image Analysis
Corporation, Nashville, TN) in a blinded fashion.
Calcein labeling
2 month old male FF and control littermates were injected intraperitoneally with calcein
(Sigma) (7.5 mg/kg of body weight) on days 6 and 2 before sacrifice. Non-decalcified histologi-
cal sections of femur were analyzed using BioQuant OsteoII (BioQuant Image Analysis Corpo-
ration, Nashville, TN).
Microcomputed tomography (μCT)
Trabecular bone was scanned using μCT40 scanner (Scanco Medical AG, Bassersdorf, Switzer-
land; 55 kVp, 145 μA, 300 ms integration time, 16 μm voxel size). A lower threshold of 250 was
used for evaluation of all scans. The trabecular bone region of interest consisted of 100 slices
that were drawn starting with the first slice in which condyles and primary spongiosa were no
longer visible, constituting 1.6 mm in length. The region of interest of cortical analyses con-
sisted of 50 slices covering a length of 0.8 mm at the femur midshaft.
Fat transplantation
Primary mouse embryonic fibroblasts (MEFs) were prepared from WT C57/BL6 E14 embryos
as described [9, 45]. MEFs were injected subcutaneously at the sternum of 2 month old FF
mice as reported [9, 46]. Mice were sacrificed 4 months after transplantation.
Mature fat depots were transplanted as described [47] with slight modification. 2 month
old FF mice were anesthetized with isoflurane. Donor fat pads from 6–8 week old WT or adi-
pokine deficient mice were placed into sterile PBS and cut into 100-150mg pieces. The grafts
were implanted subcutaneously through small incisions in the shaved skin of the back, with 1
piece per incisions. 6 pieces of fat graft were implanted into each FF mouse. After surgery the
mice were housed individually for a week and then 5 mice per cage. Mice were sacrificed 3
months after transplantation.
Biomechanics
Femora (n = 5 per group) were scanned by microCT at the midshaft (Scanco uCT40; 70 kVp,
114 mA, 300 ms integration time, 10 um voxel size, 100 slices) to determine cross-sectional
geometric properties. They were then mechanically tested to failure in three-point pending
(Instron 8841; support span: 7 mm; displacement rate: 0.1 mm/sec). Failure occurred directly
beneath the loading point, at the 50% length of the femur. Force-displacement data were col-
lected and analyzed to determine whole-bone (structural) mechanical properties (stiffness,
ultimate force, post-yield displacement, work-to-fracture) [14].
Statistics
Statistical significance was determined using Student’s t test, one way or 2 way ANOVA test
with Holm-Sidak post–hoc test with adjustment for multiple testing. Data are expressed as
mean ± SD. �p < 0.05, ��p< 0.01, ���p< 0.001 in all experiments.
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Supporting information
S1 Fig. FF mice have splenomegaly. Age-dependent a) Body weight; B) femur length; C) ratio
of spleen per body weight of FF and control littermates. Data are presented as mean ± SD.��
p<0.01; ��� p<0.001 as determined by unpaired t test (C) and 2 way ANOVA with Holm-
Sidak’s post hoc analysis for multiple comparisons test (A,B).
(TIF)
S2 Fig. Congenital absence of fat promotes osteosclerosis. μCT quantitation of structural
model index (SMI), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular spac-
ing (Tb.Sp) and connection density (Conn.Dens) of 3 month old control and FF. A) femur
and B) vertebrae. Data are presented as mean ± SD. �p<0.05; ���p<0.001 as determined by
unpaired t test.
(TIF)
S3 Fig. Congenital absence of fat promotes osteosclerosis. A) Age-dependent μCT images of
femur diaphyseal mid-shaft region of FF and control littermates; B) μCT quantitation of A.
Data are presented as mean ± SD. �p<0.05; ��p<0.01; ��� p<0.001 as determined by 2 way
ANOVA with Holm-Sidak’s post hoc analysis for multiple comparisons test.
(TIF)
S4 Fig. Congenital absence of fat decreases marrow LepR+ cells. A) Flow cytometry assay of
Lin-LepR+ cell number B) and ratio of Lin-Lep+ per total cell in femur marrow of 7 weeks old
FF and control littermates. Data are presented as mean ± SD. �p<0.05; ��p<0.01; as deter-
mined by unpaired t test. C) Histological section of 3 month old FF and control tibia stained
for TRAP activity (red reaction product). Marrow adipocytes are present in both genotypes
(arrow).
(TIF)
S5 Fig. Osteosclerosis of FF mice is not caused by the metabolic syndrome. μCT quantita-
tive analysis of distal femurs of FF mice following 3 months with or without metformin. Data
are presented as mean ± SD.
(TIF)
S6 Fig. MEF transplantation normalizes FF skeleton. μCT quantitative analysis of distal
femurs of FF mice 4 months after sham operation or MEF transplantation. Data are presented
as mean ± SD. �p<0.05; ��� p<0.001 as determined by ANOVA with Holm-Sidak’s post hoc
analysis for multiple comparisons test.
(TIF)
S7 Fig. Transplanted WT adipose tissue normalizes FF skeleton. A) Serum leptin and adipo-
nectin of FF mice 3 months after WT fat depot transplantation. μCT B) images and C) quanti-
tative analysis of distal femurs of FF mice 3 months after sham operation or transplantation of
various fat depots. D) μCT quantitative analysis of femur diaphyseal mid-shaft region of FF
mice 3 months after sham operation or transplantation of various fat depots. Data are pre-
sented as mean ± SD. �p<0.05; ��p<0.01; ��� p<0.001; NS, not significant as determined by
ANOVA with Holm-Sidak’s post hoc analysis for multiple comparisons test.
(TIF)
S8 Fig. BAT deletion does not increase bone mass. μCT quantitative analysis of femurs of
three month old DTA-UCP1 Cre mice. Data are presented as mean ± SD.
(TIF)
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S9 Fig. Absence of leptin and adiponectin moderates FF osteosclerosis. A) μCT analysis of
distal femurs of FF mice 3 months after sham operation or transplantation of fat derived from
WT or adipokine-deficient mice; B) Histomorphometric analysis of osteoclast number of FF
and control femur 3 months after sham operation or transplantation of fat derived from WT
or adipokine-deficient mice; C) Serum TNFα of control mice and FF mice 3 months after
sham operation or transplantation of fat derived from WT or adipokine-deficient mice. Data
are presented as mean ± SD. �p<0.05; ��p<0.01; ��� p<0.001 as determined by ANOVA with
Holm-Sidak’s post hoc analysis for multiple comparisons test. A) Comparison with Sham
except where detailed.
(TIF)
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